What does Diergeneeskunde dr. Tom Mariën do?

Diergeneeskunde dr. Tom Mariën is a veterinary practice in Lummen. Private Limited, started on 28 January 2021, 1 establishment.

What is the address of Diergeneeskunde dr. Tom Mariën?

The registered office of Diergeneeskunde dr. Tom Mariën is located at Venusbergstraat 1, 3560 Lummen.

Is Diergeneeskunde dr. Tom Mariën still active?

Yes. According to the CBE (29 September 2026) Diergeneeskunde dr. Tom Mariën is active, legal situation “Normale toestand”, started on 28 January 2021.

Is Diergeneeskunde dr. Tom Mariën registered on Peppol?

Yes, Diergeneeskunde dr. Tom Mariën is registered on the Peppol network with ID 0208:0762643001.

What is the enterprise number of Diergeneeskunde dr. Tom Mariën?

The enterprise number of Diergeneeskunde dr. Tom Mariën is BE0762643001.

When was Diergeneeskunde dr. Tom Mariën founded?

Diergeneeskunde dr. Tom Mariën was founded on 28 January 2021.

Who are the directors of Diergeneeskunde dr. Tom Mariën?

According to the 2025 annual accounts, the directors of Diergeneeskunde dr. Tom Mariën are: Tom Mariën.

Is Diergeneeskunde dr. Tom Mariën a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 28 January 2021; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did Diergeneeskunde dr. Tom Mariën make in 2025?

Diergeneeskunde dr. Tom Mariën posted a profit after taxes of € 25,953 in financial year 2025.

What is the revenue of Diergeneeskunde dr. Tom Mariën?

As a small company, Diergeneeskunde dr. Tom Mariën is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 43,227.

Diergeneeskunde dr. Tom Mariën (Private Limited) - Lummen

Dossier Diergeneeskunde dr. Tom Mariën, printed on 29 September 2026 from databakkes.be/en/0762643001/diergeneeskunde-dr-tom-marien. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Diergeneeskunde dr. Tom Mariën from Lummen, company number BE0762643001, closed financial year 2025 with a result of € 25,953 after tax. For that financial year Diergeneeskunde dr. Tom Mariën recorded a gross margin of € 43,227 and equity of € 3,384. Compared with financial year 2024, the result moved from € 30,273 to € 25,953. The company is profitable. The buffer shrank hard: equity is 54 % below last year. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on July 1, 2026.

What it is worth Shrank hard

€ 3,384

▼ 54% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 25,953

▼ 14% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 61,499

▲ 4% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 30,000 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 13,544

▲ € 13,407 vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 14,067

▼ 34% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 16,430 Gross margin 2022: € 16,430 First fiscal year in the series	€ 44,034 Gross margin 2023: € 44,034 ▲ 168% vs 2022 (€ 16,430) Favourable step	€ 43,444 Gross margin 2024: € 43,444 ▼ 1% vs 2023 (€ 44,034) Unfavourable step	€ 43,227 Gross margin 2025: € 43,227 ▼ 1% vs 2024 (€ 43,444) Unfavourable step	▼ 1%
Profit after taxes	€ 12,499 Profit after taxes 2022: € 12,499 First fiscal year in the series	€ 34,385 Profit after taxes 2023: € 34,385 ▲ 175% vs 2022 (€ 12,499) Favourable step	€ 30,273 Profit after taxes 2024: € 30,273 ▼ 12% vs 2023 (€ 34,385) Unfavourable step	€ 25,953 Profit after taxes 2025: € 25,953 ▼ 14% vs 2024 (€ 30,273) Unfavourable step	▼ 14%
Equity	€ 57,773 Equity 2022: € 57,773 First fiscal year in the series	€ 17,157 Equity 2023: € 17,157 ▼ 70% vs 2022 (€ 57,773) Unfavourable step	€ 7,431 Equity 2024: € 7,431 ▼ 57% vs 2023 (€ 17,157) Unfavourable step	€ 3,384 Equity 2025: € 3,384 ▼ 54% vs 2024 (€ 7,431) Unfavourable step	▼ 54%
Total debts	€ 16,257 Total debts 2022: € 16,257 First fiscal year in the series	€ 85,044 Total debts 2023: € 85,044 ▲ € 68,787 vs 2022 (€ 16,257) Unfavourable step	€ 62,038 Total debts 2024: € 62,038 ▼ 27% vs 2023 (€ 85,044) Favourable step	€ 58,571 Total debts 2025: € 58,571 ▼ 6% vs 2024 (€ 62,038) Favourable step	▼ 6%
Cash	€ 73,096 Cash 2022: € 73,096 First fiscal year in the series	€ 101,769 Cash 2023: € 101,769 ▲ 39% vs 2022 (€ 73,096) Favourable step	€ 59,041 Cash 2024: € 59,041 ▼ 42% vs 2023 (€ 101,769) Unfavourable step	€ 61,499 Cash 2025: € 61,499 ▲ 4% vs 2024 (€ 59,041) Favourable step	▲ 4%
Retained profit	€ 55,273 Retained profit 2022: € 55,273 First fiscal year in the series	€ 14,657 Retained profit 2023: € 14,657 ▼ 73% vs 2022 (€ 55,273) Unfavourable step	€ 4,931 Retained profit 2024: € 4,931 ▼ 66% vs 2023 (€ 14,657) Unfavourable step	€ 884 Retained profit 2025: € 884 ▼ 82% vs 2024 (€ 4,931) Unfavourable step	▼ 82%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 75,000 Dividend 2023: € 75,000 Unchanged (€ 0) Unchanged	€ 40,000 Dividend 2024: € 40,000 ▼ 47% vs 2023 (€ 75,000) Unchanged	€ 30,000 Dividend 2025: € 30,000 ▼ 25% vs 2024 (€ 40,000) Unchanged	▼ 25%
Balance sheet total	€ 74,030 Balance sheet total 2022: € 74,030 First fiscal year in the series	€ 102,201 Balance sheet total 2023: € 102,201 ▲ 38% vs 2022 (€ 74,030) Unchanged	€ 69,468 Balance sheet total 2024: € 69,468 ▼ 32% vs 2023 (€ 102,201) Unchanged	€ 61,955 Balance sheet total 2025: € 61,955 ▼ 11% vs 2024 (€ 69,468) Unchanged	▼ 11%

Key figures of Diergeneeskunde dr. Tom Mariën, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Diergeneeskunde dr. Tom Mariën?

What happened at Diergeneeskunde dr. Tom Mariën in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 1, 2026 New annual accounts for financial year 2025: profit of € 25,953 (▼ 14% vs 2024). Source: NBB ↗
Jan 28, 2021 New establishment in Lummen. KBO
2021 Tom Mariën became a director. NBB
Jan 28, 2021 Start of the company according to the CBE. KBO

In short

From € 12,499 profit in 2022 to € 25,953 profit in 2025.

Paid € 39,769 in corporate taxes since 2022.

Best year ever: 2023, with € 34,385 profit.

Paid out € 145,000 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at Diergeneeskunde dr. Tom Mariën? We notify you, reason included.

Follow Diergeneeskunde dr. Tom Mariën

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Tom Mariën

Diergeneeskunde dr. Tom Mariën

ECG Clinics

ECG Labs

ECG Medical Care

Behind Diergeneeskunde dr. Tom Mariën is Tom Mariën. Tom Mariën is also behind ECG Clinics, ECG Labs, ECG Medical Care, ECG Nutrition and Supplements and EQUITOM.

See the full network in the app

Directors

According to the 2025 annual accounts

Tom Mariën

Director

Also active at: ECG Clinics, ECG Labs, ECG Medical Care, ECG Nutrition and Supplements, EQUITOM, ECG Ambulatory Care, T&K Partners

since 2021

Establishments

Establishment units

Physical locations of this company

Registered office

Venusbergstraat 1

3560 Lummen

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

SHATAL

€ 1.4 million revenue · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0762.643.001
VAT number: BE 0762.643.001
Registered office: Venusbergstraat 1, 3560 Lummen
Names & denominations: Diergeneeskunde dr. Tom Mariën
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 28 January 2021
Peppol: Active · Active since 6 Jan 2026
Activities · NACE: Veterinaire diensten

View on CBE Public ↗ Annual accounts (NBB) ↗